LEMONADE INC (LMND) Forecast, Price Target & Analyst Ratings
NYSE:LMND • US52567D1072
51.86 USD
-1.4 (-2.63%)
At close: Mar 3, 2026
53.37 USD
+1.51 (+2.91%)
Pre-Market: 3/4/2026, 8:28:16 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LEMONADE INC (LMND).
Forecast Snapshot
Consensus Price Target
$66.41
+ 28.06% Upside
Next Earnings Forecast
Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate-$0.55
Revenue Estimate255.43M
ChartMill Buy Consensus
68.89%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$66.41
Upside
+ 28.06%
From current price of $51.86 to mean target of $66.41, Based on 18 analyst forecasts
Low
$33.33
Median
$66.30
High
$102.90
Price Target Revisions
1 Month
-1.01%
3 Months
28.30%
Price Target Summary
18 analysts have analysed LMND and the average price target is 66.41 USD. This implies a price increase of 28.06% is expected in the next year compared to the current price of 51.86.
The average price target has been revised upward by 28.3% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
68.89%
LMND was analyzed by 18 analysts. The buy percentage consensus is at 69. So analysts seem to be have mildly positive about LMND.
In the last month the buy percentage rose by 15 points. So the trust of analysts is improving.
LMND was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-24 | Keefe, Bruyette & Woods | Maintains | Underperform -> Underperform |
| 2026-01-14 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2026-01-06 | Truist Securities | Initiate | Buy |
| 2025-11-25 | Keefe, Bruyette & Woods | Maintains | Underperform -> Underperform |
| 2025-11-24 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-17 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-11-10 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-10-10 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-10-07 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-09-17 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-08-18 | BMO Capital | Maintains | Underperform -> Underperform |
| 2025-07-14 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-07-02 | BMO Capital | Maintains | Underperform -> Underperform |
| 2025-07-01 | Keefe, Bruyette & Woods | Reiterate | Underperform -> Underperform |
| 2025-04-22 | Keefe, Bruyette & Woods | Maintains | Underperform -> Underperform |
| 2025-04-08 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2025-02-26 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-26 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-11-22 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-11-21 | BMO Capital | Maintains | Underperform -> Underperform |
| 2024-11-21 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-11-20 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2024-11-15 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2024-11-07 | Keefe, Bruyette & Woods | Downgrade | Market Perform -> Underperform |
| 2024-11-01 | Piper Sandler | Maintains | Neutral -> Neutral |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate-$0.55
Revenue Estimate255.43M
Revenue Q2Q68.94%
EPS Q2Q36.46%
Number of Analysts13
Next Earnings Revisions
Revenue (1 Month)
3.55%
Revenue (3 Months)
3.32%
EPS (1 Month)
2.52%
EPS (3 Months)
-1.90%
Next Earnings Summary
LMND is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.55 USD and the consensus revenue estimate is 255.43M USD.
The next earnings revenue estimate has been revised upward by 3.32% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 429.8M 67.43% | 526.5M 22.50% | 737.9M 40.15% | 1.181B 60.05% | 1.55B 31.24% | 2.097B 35.29% | 2.661B 26.90% | 3.409B 28.11% | 4.292B 25.90% | |
| EBITDA YoY % growth | -209.8M 25.76% | -183.9M 12.35% | -148M 19.52% | -60.671M 59.01% | 39.27M 164.73% | 154.43M 293.25% | 296.82M 92.20% | 476.14M 60.41% | 728.59M 53.02% | |
| EBIT YoY % growth | -229.8M 22.05% | -203.9M 11.27% | -163.2M 19.96% | -124.701M 23.59% | -56.296M 54.86% | 92.82M 264.88% | N/A | N/A | N/A | |
| Operating Margin | -53.47% | -38.73% | -22.12% | -10.56% | -3.63% | 4.43% | N/A | N/A | N/A | |
| EPS YoY % growth | -3.41 26.03% | -2.85 16.42% | -2.26 20.70% | -1.67 26.29% | -0.83 50.41% | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.55 36.46% | -0.57 5.17% | -0.43 15.31% | -0.13 56.16% | -0.31 43.07% | -0.33 42.57% | -0.26 39.94% | 0.04 130.76% | -0.03 91.48% | -0.03 90.01% | 0.07 128.70% |
| Revenue Q2Q % growth | 255.43M 68.94% | 290.36M 76.94% | 315.56M 62.24% | 329.91M 44.63% | 338.61M 32.56% | 361.19M 24.39% | 388.45M 23.10% | 416.44M 26.23% | 483.6M 42.82% | 514.58M 42.47% | 550.22M 41.64% |
| EBITDA Q2Q % growth | -22.519M 60.42% | -23.621M 29.28% | -11.38M 51.98% | 6.938M 228.48% | -5.406M 75.99% | -5.1M 78.41% | 5.406M 147.50% | 32.334M 366.04% | 24.174M 547.17% | 23.256M 556.00% | 34.884M 545.28% |
| EBIT Q2Q % growth | -42.942M 30.06% | -41.871M 1.71% | -22.134M 39.02% | -14.025M 31.92% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
41.61%
Revenue Next 5 Year
35.79%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
42.38%
EBIT Next 5 Year
36.47%
LEMONADE INC / LMND Forecast FAQ
What do analysts expect the price target to be for LEMONADE INC (LMND)?
18 analysts have analysed LMND and the average price target is 66.41 USD. This implies a price increase of 28.06% is expected in the next year compared to the current price of 51.86.
When does LEMONADE INC (LMND) report earnings?
LEMONADE INC (LMND) will report earnings on 2026-05-04, after the market close.
Can you provide the consensus estimates for LEMONADE INC next earnings?
The consensus EPS estimate for the next earnings of LEMONADE INC (LMND) is -0.55 USD and the consensus revenue estimate is 255.43M USD.
What is the expected long term growth rate for LEMONADE INC (LMND)?
The expected long term growth rate for LEMONADE INC (LMND) is 41.61%.